Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Beginning Balance at Dec. 31, 2021	$ 1,015	$ 104,103,325	$ (48,921)	$ (65,318,360)	$ 38,737,059
Beginning Balance (in Shares) at Dec. 31, 2021	1,014,870
Sale of common stock, net of offering costs	$ 4	404,551			404,555
Sale of common stock, net of offering costs (in Shares)	4,160
Sales of common stock and warrants through public offering, net of offering costs	$ 427	11,235,199			11,235,626
Sales of common stock and warrants through public offering, net of offering costs (in Shares)	427,000
Issuance of common stock for stock option exercises	$ 2	110,820			$ 110,822
Issuance of common stock for stock option exercises (in Shares)	1,692				1,692
Stock-based compensation		4,251,833			$ 4,251,833
Foreign currency translation adjustment			(90,374)		(90,374)
Net loss				(31,770,062)	(31,770,062)
Ending Balance at Dec. 31, 2022	$ 1,448	120,105,728	(139,295)	(97,088,422)	$ 22,879,459
Ending Balance (in Shares) at Dec. 31, 2022	1,447,722				1,447,722
Sales of common stock through the at-the-market offering	$ 7	60,258			$ 60,265
Sales of common stock through the at-the-market offering (in Shares)	7,062
Costs related to the at-the-market offering		(108,700)			(108,700)
Sales of common stock and in public offering, net of offering costs	$ 915	5,063,807			5,064,722
Sales of common stock and in public offering, net of offering costs (in Shares)	915,216
Cash paid for fractional shares resulting from reverse stock split		(2,875)			(2,875)
Stock-based compensation		2,926,291			2,926,291
Foreign currency translation adjustment			(8,897)		(8,897)
Net loss				(21,243,231)	(21,243,231)
Ending Balance at Dec. 31, 2023	$ 2,370	$ 128,044,509	$ (148,192)	$ (118,331,653)	$ 9,567,034
Ending Balance (in Shares) at Dec. 31, 2023	2,370,000				2,370,000